2m 2m 2m 2m 2m 2m 2m
NURIX THERAPEUTC-RG (NRIX)
NASDAQ
$16.50+$0.62 (+3.90%)
Price as of Nov 11, 2026 7:30 PM EST- $1.7BMarket Cap
- 23.48%1-Year Change
- BiotechnologyIndustry
NURIX THERAPEUTC-RG (NRIX)
$16.50+$0.62 (+3.90%)
NRIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.88 | ||
Change | -$0.26 (-1.61%) | ||
Open | $16.00 | ||
High | $16.76 | ||
Low | $15.75 | ||
Previous Close | $16.14 | ||
Volume | 3,048,914 | ||
30-Day Average Volume | 4,171,359 | ||
1-Week Change | -38.50% | ||
1-Month Change | -28.95% | ||
1-Year Change | 23.48% | ||
3-Year Change | 201.33% | ||
5-Year Change | -52.57% | ||
Fundamentals | |||
Shares Outstanding | 109.2M | ||
Total Assets | $1.2B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $19.9M | ||
Net Income | $549.8M | ||
Free Cash Flow | $614.2M | ||
EBIT | $563.4M | ||
EBITDA | $565.6M | ||
Net Working Capital | $973.0M | ||
EPS | $4.73 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 2 | ||
P/E | 3 | ||
PEG | 0 | ||
Price/Free Cash Flow | 3 | ||
Price/Operating Cash Flow | 3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue